Sort
51,570 grants matching “autoimmune disease”
Hormone, cytokine, and genetic risks for RA in women
$518,211Elizabeth W Karlson · Brigham And Women'S Hospital · R01 · FY2006 · AR
A TCF1:Glucocorticoid regulatory circuit controls IL-23-driven Th17 pathogenicity
$518,040Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2023 · AI
Inflammation, Macrophage Differentiation, and Cancer
$517,920Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Protein Characterization By Mass Spectrometry
$517,864Kenneth Tomer · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Molecular and Cellular Immunology
$517,734Jason G. Cyster · University Of California, San Francisco · T32 · FY2021 · AI
Proteomic changes/progression of human type 1 diabetes
$517,676Jin-Xiong She · Augusta University · R33 · FY2006 · HD
Characterizing the genetic and evolutionary determinants of population variation in transcriptional responses to pathogens
$517,611Luis Bruno Barreiro · University Of Chicago · R35 · FY2025 · GM
Characterizing the genetic and evolutionary determinants of population variation in transcriptional responses to pathogens
$517,611Luis Bruno Barreiro · University Of Chicago · R35 · FY2024 · GM
Mediator kinases as interferon antagonists in Down Syndrome
$517,578Dylan J Taatjes · University Of Colorado · R01 · FY2022 · AI
Mitochondrial DNA Stress Activation of Interferon Signaling and Lupus Pathology
$517,565Gerald S Shadel · Salk Institute For Biological Studies · R01 · FY2018 · AR
Apoptosis in Sjogrens Syndrome
$517,523Antony Rosen · Johns Hopkins University · R37 · FY2007 · DE
Engineering and Analysis of T cell CD3 and IL2R Signals
$517,512Massachusetts Institute Of Technology · R01 · FY2005 · AI
The genetic basis of type 1 diabetes autoimmunity in African Americans
$517,510Janelle A Noble · Children'S Hospital & Res Ctr At Oakland · R01 · FY2012 · DK
A TCF1:Glucocorticoid regulatory circuit controls IL-23-driven Th17 pathogenicity
$517,503Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2024 · AI
Complement system and humoral immunity
$517,500Michael Craig Carroll · Immune Disease Institute, Inc. · R01 · FY2011 · AI
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
$517,434David Oupicky · University Of Nebraska Medical Center · R01 · FY2022 · DK
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
$517,434David Oupicky · University Of Nebraska Medical Center · R01 · FY2020 · DK
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
$517,434David Oupicky · University Of Nebraska Medical Center · R01 · FY2021 · DK
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
$517,434David Oupicky · University Of Nebraska Medical Center · R01 · FY2023 · DK
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
$517,415Justin M Balko · Vanderbilt University Medical Center · R01 · FY2021 · CA
Dissecting transcriptomics and epigenomic signatures of immune cells in type 1 diabetes
$517,339Golnaz Vahedi · University Of Pennsylvania · U01 · FY2021 · DK
Antibody Mediated Immune Regulation
$517,331James C. Zimring · Bloodworks · P01 · FY2018 · HL
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
$517,329Anton Wellstein · Georgetown University · R01 · FY2019 · CA
Nanotechnology Enabled Selection of MHC-Peptide Ligands to Personalize Cancer Therapy
$517,321Georgios Alexandrakis · University Of Texas Arlington · R21 · FY2020 · CA
The role of cytotoxic T cells in rheumatoid arthritis pathogenesis
$517,284Felipe Andrade · Johns Hopkins University · R01 · FY2025 · AR